GSDMD and Sepsis: By targeting Arg7 residues, GI-Y1 inhibits the interaction between PM and GSDMD-NT and decreases the secretion of inflammatory cytokines, thereby increasing the sepsis survival rate and providing protection against myocardial I/R injury and cardiac remodeling in mice.